Joseph E. Labrie
Impact in
- Microbiology top 5%
- Bacterial Infections and Vaccines
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Bacterial Infections and Vaccines 4
-
- Immunotherapy and Immune Responses 2
- Immune Response and Inflammation 2
- T-cell and B-cell Immunology 2
- Co-authors
- Rachel M. Gerstein (3 shared papers)Michael P. Cancro (1 shared paper)Paul B. Keiser (3 shared papers)Valerian B. Pinto (3 shared papers)Wendell D. Zollinger (3 shared papers)Deborah H. Schmiel (2 shared papers)Mark B. Stoddard (2 shared papers)Ping Chen (2 shared papers)
- Journals
- Vaccine (2 papers)Neuro-Oncology (1 paper)Seminars in Immunology (1 paper)Clinical and Vaccine Immunology (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Joseph E. Labrie
7 papers receiving 371 citations
Peers
Comparison fields: 5 of 54
- Microbiology 126
- Immunology 131
- Genetics 43
- Epidemiology 127
- Aging 5
Countries citing papers authored by Joseph E. Labrie
This map shows the geographic impact of Joseph E. Labrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Labrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Labrie more than expected).
Fields of papers citing papers by Joseph E. Labrie
This network shows the impact of papers produced by Joseph E. Labrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Labrie. The network helps show where Joseph E. Labrie may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph E. Labrie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 127 | |
| 2 | 2008 | 82 | |
| 3 | 2010 | 64 | |
| 4 | 2010 | 57 | |
| 5 | 2005 | 30 | |
| 6 | 2012 | 18 | |
| 7 | 2010 | 4 |
About Joseph E. Labrie
Joseph E. Labrie is a scholar working on Microbiology, Immunology, Epidemiology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 7 papers that have together received 382 indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (4 papers), Pneumonia and Respiratory Infections (4 papers), Neonatal and Maternal Infections (2 papers), Immunotherapy and Immune Responses (2 papers), Immune Response and Inflammation (2 papers), T-cell and B-cell Immunology (2 papers), Cancer Mechanisms and Therapy (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Microbiology (126 citations), Immunology (131 citations), Genetics (43 citations), Epidemiology (127 citations) and Aging (5 citations). Joseph E. Labrie has collaborated with scholars based in United States. Frequent co-authors include Rachel M. Gerstein, Michael P. Cancro, Paul B. Keiser, Valerian B. Pinto, Wendell D. Zollinger, Deborah H. Schmiel, Mark B. Stoddard, Ping Chen, Evgenia D. Pak and Larry D. Recht. Their work appears in journals such as Vaccine, Neuro-Oncology, Seminars in Immunology, Clinical and Vaccine Immunology and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.